Talk:AV965
Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
This article is rated Start-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:
It is of interest to the following WikiProjects:
WikiProject icon This article is within the scope of WikiProject Pharmacology , a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Low This article has been rated as Low-importance on the project's importance scale.
Problems with page
[edit ]There are some issues with this article's sourcing.
- The first paragraph of "Mechanism of action" cites three sources (#1-#3 in the current [as of 4 June 2026] version of the article) none of which mention AV965 in the main text of the publication.
- The BioWorld Science reference (#4) is to a list of articles, and there is no mention of AV965 on the linked page.
- It is not clear what makes teaserclub.com a reliable source. The website for investors is source #5.
- The source titled "Regulatory Requirements for the Clinical Development of New Therapies for the Treatment of Alzheimer's Disease" (#6) is a Masters thesis. WP:THESIS which says "Masters dissertations and theses are considered reliable only if they can be shown to have had significant scholarly influence." There is no indication this threshold has been met.
🏰 Richard Nevell (talk) 20:45, 4 June 2026 (UTC) [reply ]
- What I stated here applies to this article too. NorthernWinds ❄️ (talk) 23:02, 7 June 2026 (UTC) [reply ]